2024
DOI: 10.1016/j.omton.2024.200775
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22

Scott McComb,
Mehdi Arbabi-Ghahroudi,
Kevin A. Hay
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 41 publications
0
0
0
Order By: Relevance